Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
Clinical trial NCT01239394 · COMPLETED
Trial details
- NCT number
- NCT01239394
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.